Heart Surgery Drug Trasylol Withdrawn from Market By Levine & Slavit PLLC on November 11, 2007

The German pharmaceutical company, Bayer AG, announced that it will withdraw Trasylol, its controversial drug used for heart surgery, from the market. The withdrawal was due in part to a study performed in Canada which suggested that Trasylol increased rates of death. The New England Journal of Medicine published the results of a study it conducted finding that Trasylol increased the risks of stroke, heart attack, kidney failure, and death. The research concluded that stopping the use of Trasylol would result in the prevention of 10,000 to 11,000 cases of kidney failure per year along with the savings of over $1 billion dollars per year in the cost of dialysis. Bayer AG received pressure from the Food and Drug Administration to pull Trasylol from the market. According to Dr. John K. Jenkins, one of the F.D.A's leading officials, the F.D.A. was not able to identify a specific population of patients where Traysol's use would result in benefits outweighing its risks. Trasylol works by blocking the enzymes which dissolve blood clots. The F.D.A. may have approved the drug based on the assumption that any drug that reduces excessive bleeding during the course of heart surgery would be beneficial to patients. The F.D.A. similarly, in the interests of speed, often approves drugs that have not been shown to exend life but have proved effecive in lowering cholesteraol, shrinking tumors, moderating blood sugar or causing other effects. Once approved, halting sales is exceedingly difficult. Earlier this year, the U.S. Food and Drug Administration issued a safety alert over the drug Avandia. The F.D.A. noted that safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia. The personal injury lawyers at Levine & Slavit have decades of experience handling personal injury claims including those involving dangerous and defective products . For 50 years spanning 3 generations, we have obtained results for satisfied clients. If you or someone close to you has been injured or killed by a product that was not properly manufactured, designed or labeled, contact the personal injury lawyers at Levine & Slavit for their help. We have offices in Manhattan and Long Island, handling cases in New York City, the Bronx, Brooklyn, Queens and surrounding areas.

Related to This

Levine & Slavit, PLLC Logo

Levine & Slavit, PLLC

The law firm of Levine & Slavit, PLLC has served clients in Long Island and the Greater New York City-area since 1957. We are a team of personal injury and wrongful death lawyers who work tirelessly for victims' rights. Our team is licensed and affiliated with the:

  • New York State Bar Association
  • New Jersey Board of Bar Examiners
  • Florida Board of Bar Examiners
  • U.S. District Court Eastern District of New York
  • U.S. District Court Southern District of New York

Please contact our practice online for a free consultation or call (212) 687-2777 to speak to an attorney today. 

Contact Us Today

Rate, Review & Explore

Social Accounts Sprite
Google map image of our location in 60 E 42nd St Ste 2101 New York, NY

Manhattan Office

60 E 42nd St
Ste 2101
New York, NY 10165

Closed Today

By Appointment Only

Google map image of our location in 350 Willis Ave Ste 100 Long Island, NY

Mineola Office

350 Willis Ave
Ste 100
Long Island, NY 11501

Closed Today

By Appointment Only

(212) 687-2777 Send a message